NCT07015073 Comparative of Sequential Application of Pulsed Dye Laser and Potassium-titanyl-phosphate Laser Treatment for Capillary Malformations Versus Single Application
| NCT ID | NCT07015073 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal |
| Condition | Port-Wine Stains (Capillary Malformations) |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-12-01 |
| Primary Completion | 2025-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-12-01 with a primary completion date of 2025-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective, non-randomized study aims to evaluate the efficacy and tolerability of treating port-wine stains (capillary malformations) using pulsed dye laser (PDL), potassium titanyl phosphate (KTP) laser, or a sequential combination of both. Each participant will receive all three treatments on different areas of the lesion. The primary outcome is improvement measured using the Investigator Global Assessment (IGA) scale. Secondary outcomes include pain (VAS), local adverse events, and patient satisfaction.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 * Fitzpatrick skin types I-IV * Presence of port-wine stain Exclusion Criteria: * Open wounds in treatment area * Pregnancy * Nearby metal implants * Photodermatoses
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07015073 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Port-Wine Stains (Capillary Malformations). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07015073 currently recruiting?
Yes, NCT07015073 is actively recruiting participants. Contact the research team at jorgenrmed@gmail.com for enrollment information.
Where is the NCT07015073 trial being conducted?
This trial is being conducted at Madrid, Spain.
Who is sponsoring the NCT07015073 clinical trial?
NCT07015073 is sponsored by Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal. The trial plans to enroll 30 participants.